Novel biomarker appears predictive of outcome in patients with HPV-related head and neck cancers

(University of Texas M. D. Anderson Cancer Center) Rather than classifying based solely on HPV status, MD Anderson researchers have discovered a new biomarker for head and neck cancers that may enable clinicians to better predict patient outcomes and lower treatment intensity to reduce side effects.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news